image
Healthcare - Biotechnology - NASDAQ - US
$ 0.2718
4.18 %
$ 17.5 M
Market Cap
-0.46
P/E
BALANCE SHEET
11.1 B ASSETS
24375.54%
5.78 B LIABILITIES
83612.40%
5.31 B EQUITY
13732.21%
BALANCE SHEET DECOMPOSITION
Balance Sheet GlycoMimetics, Inc.
image
Current Assets 11.1 B
Cash & Short-Term Investments 10.7 B
Receivables 137 K
Other Current Assets 371 M
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 5.78 B
Accounts Payable 329 K
Short-Term Debt 66.9 M
Other Current Liabilities 5.71 B
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 10.7 41.8 47.9 90.3 137.0 158.2 209.9 123.9 40.0 46.8 55.2 2.3 17.4 28.2
Short Term Investments 10 709.5 0 0 0 0 0 0 0 10.6 K 9.27 K 16.3 K 1 K 0 0
Receivables 0.1 0.2 0.1 1.35 K 2.15 K 0.2 0.4 0.1 0.3 38.7 K 22.3 K 0 0 0
Inventory 0 0 (0.1) (533.8) (1 237.1) (4 322.2) 405 0 0.2 0.4 77 0 0 0
Other Current Assets 371.3 1.8 2.7 0.5 1.2 4.1 1.9 3.2 0.2 0.4 0.9 2.6 0.6 0.2
Total Current Assets 11 091.5 43.8 50.7 90.3 138.3 162.5 212.3 127.2 40.5 47.2 56.1 4.9 18.0 28.4
PP&E 0 0.8 1.0 1.9 2.9 3.8 1.0 1.1 1.1 0.5 0.5 0.4 0.5 0.2
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0.8 0.1 2.1 1.6 1.6 1.6 0.3 0.8 0.7 0.7 0 (0.5) 0.3
Other Assets 0 0 411 0 169 321 272 0 327 279 27 0 0 0
Total Assets 11 091.5 45.3 51.8 94.3 142.8 168.0 214.8 128.6 42.4 48.5 57.3 5.3 18.4 28.9
LIABILITIES
Accounts Payable 0.3 0.9 1.0 2.1 2.1 1.4 2.7 2.6 1.6 0.6 0.9 1.1 0.8 0.5
Short Term Debt 66.9 0.7 0.9 1.0 0.9 0.8 0 0 0 0 0 0 0 0
Other Current Liabilities 5 710.7 5.2 7.0 8.7 9.4 8.7 6.1 5.5 4.8 7.2 5.6 1.1 0.9 0.8
Total Current Liabilities 5 777.9 6.8 8.9 11.8 12.4 11.0 8.8 8.2 6.3 7.7 6.5 2.3 5.7 16.4
Long Term Debt 0 66.8 K 0 0.9 1.9 2.8 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0.3 0 0.6 0.7 0.8 0.2 0 96.8 K 0.2 0
Total Liabilities 5 777.9 6.9 8.9 12.7 14.6 13.8 9.4 8.9 7.1 8.0 6.5 2.4 5.9 20.5
EQUITY
Common Stock 64.5 K 64.4 K 54.4 K 52.3 K 49 K 43.5 K 43.2 K 34.4 K 23.2 K 19 K 18.9 K 1.43 K 10.2 K 930
Retained Earnings (494 364.4) (456.5) (419.6) (372.9) (309.5) (258.4) (200.6) (152.3) (119.0) (87.2) (74.4) (63.3) (52.7) (56.3)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (1.6) (1.3) (1.1) (0.9) (0.9) (0.8) (0.8) (0.7)
Total Equity 5 313.6 38.4 42.9 81.6 128.2 154.2 205.5 119.7 35.3 40.5 50.8 2.9 12.5 8.5
Total Liabilities and Equity 11 091.5 45.3 51.8 94.3 142.8 168.0 214.8 128.6 42.4 48.5 57.3 5.3 18.4 28.9
SHARES OUTSTANDING
Common Shares Outstanding 64.5 63.3 52.5 51.5 45.7 43.3 41.0 29.4 21.3 19.0 18.5 1.2 1.2 1.2